. Elemental analysis data for the drug intercalates prepared by ion exchange. NM = not measured. Table S3 . Elemental analysis data for the drug intercalates prepared by self-assembly. NM = not measured. Figure S1 . XRD patterns of the drug intercalates prepared by coprecipitation: (a) LGdH-dic-c; (b) LGdHibu-c; (c) LGdH-nap-c. LGdH-dic-c @ pH 7.7
LGdH-dic-c @ pH 9.3
LGdH-dic-c @ pH 10 Figure S3 . SEM images of the LGdH-dic-c drug intercalates, prepared by coprecipitation.
LGdH-ibu-c @ pH 8
LGdH-ibu-c @ pH 10
LGdH-ibu-c @ pH 12 Figure S4 . SEM images of the LGdH-ibu-c drug intercalates.
LGdH-nap-c @ pH 8
LGdH-nap-c @ pH 10
LGdH-nap-c @ pH 12 Figure S5 . SEM images of the LGdH-nap-c drug intercalates. Figure S6 . IR spectra of the drug intercalates prepared by self-assembly.
LGdH-dic-sa
LGdH-ibu-sa
LGdH-nap-sa Figure S7 . SEM images of the drug intercalates prepared by self-assembly. Figure S8 : Assessment of the stability of LGdH-Cl at (a) pH 1.5 for 2 h, and (b) pH 7.4 for 24 h, as measured using the Arsenazo III assay. Data are shown for the release medium (negative control; HCl or PBS; -); GdCl 3 (positive control; -), and LGdH-Cl (-). 
(a) (b)

Bhaskar model
Avrami-Erofe'ev model (d)
Avrami-Erofe'ev model (e) Figure S10 : Fits of the Bhaskar and Avrami-Erofe'ev models to the release data for (a) LGdH-dic; (b) LGdH-ibu; (c) LGdH-nap; (d) LGdH-ibu-c (pH 8); and, (e) LGdH-ibu-c (pH 12). Figure S11 . The results of in vitro cell viability studies with solutions made from selected LGdH materials. Experiments were performed with solutions of the LGdHs at concentrations of 526 (red bars) or 270 (blue bars) μg mL -1 . Results are shown as mean ± S.D. from three independent experiments, each containing three replicates.
